The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.
PURPOSE:Osteoblasts and adipocytes are derived from mesenchymal stem cells. An imbalance in the differentiation of these lineages could affect the preservation of bone integrity. Several studies have suggested the importance of this imbalance in the pathogenesis of osteoporosis after kidney transpla...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5969759?pdf=render |
| _version_ | 1818616150746988544 |
|---|---|
| author | Mariel J Hernandez Luciene M Dos Reis Igor D Marques Maria J Araujo Cesar A M Truyts Ivone B Oliveira Fellype C Barreto Elias David-Neto Melani R Custodio Rosa M Moyses Ezequiel Bellorin-Font Vanda Jorgetti |
| author_facet | Mariel J Hernandez Luciene M Dos Reis Igor D Marques Maria J Araujo Cesar A M Truyts Ivone B Oliveira Fellype C Barreto Elias David-Neto Melani R Custodio Rosa M Moyses Ezequiel Bellorin-Font Vanda Jorgetti |
| author_sort | Mariel J Hernandez |
| collection | DOAJ |
| description | PURPOSE:Osteoblasts and adipocytes are derived from mesenchymal stem cells. An imbalance in the differentiation of these lineages could affect the preservation of bone integrity. Several studies have suggested the importance of this imbalance in the pathogenesis of osteoporosis after kidney transplant (KT), but the role of bone marrow adiposity in this process is not well known, and if the treatment with the anti-absorptive (zoledronic acid-ZA) drugs could attenuate bone loss. Thus, our objective was compare bone marrow adiposity, osteoblasts and osteocytes before and after KT, verify an association between bone remodeling process (Turnover, Volume, and Mineralization-TMV classification), the osteocyte sclerostin expression to evaluate if there is a role of Wnt pathway, as well as the effect of ZA on these cells. METHODS:We studied 29 new living-donor KT patients. One group received ZA at the time of KT plus cholecalciferol for twelve months, and the other group received only cholecalciferol. Bone biopsies were performed at baseline and after 12 months of treatment. Histomorphometric evaluation was performed in bone and bone marrow adipocytes. Sclerostin (Scl) expression in osteocytes was evaluated by immunohistochemistry. RESULTS:Some bone marrow adiposity parameters were increased before KT. After KT, some of them remained increased and they worsened with the use of ZA. In the baseline, lower bone Volume and Turnover, were associated with increased bone marrow adiposity parameters (some of them). After KT, both groups showed the same associations. Osteocyte Scl expression after KT decreased with the use of ZA. We observed also an inverse association between bone adiposity parameters and lower osteocyte sclerostin expression 12 months after KT. CONCLUSION:In conclusion, the present study suggests that KT fails to normalize bone marrow adiposity, and it even gets worse with the use of ZA. Moreover, bone marrow adiposity is inversely associated with bone Volume and Turnover, which seems to be accentuated by the antiresorptive therapy. |
| first_indexed | 2024-12-16T16:45:14Z |
| format | Article |
| id | doaj.art-66b51b3c06f9430498b4459c268dc3a8 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-16T16:45:14Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-66b51b3c06f9430498b4459c268dc3a82022-12-21T22:24:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01135e019799410.1371/journal.pone.0197994The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.Mariel J HernandezLuciene M Dos ReisIgor D MarquesMaria J AraujoCesar A M TruytsIvone B OliveiraFellype C BarretoElias David-NetoMelani R CustodioRosa M MoysesEzequiel Bellorin-FontVanda JorgettiPURPOSE:Osteoblasts and adipocytes are derived from mesenchymal stem cells. An imbalance in the differentiation of these lineages could affect the preservation of bone integrity. Several studies have suggested the importance of this imbalance in the pathogenesis of osteoporosis after kidney transplant (KT), but the role of bone marrow adiposity in this process is not well known, and if the treatment with the anti-absorptive (zoledronic acid-ZA) drugs could attenuate bone loss. Thus, our objective was compare bone marrow adiposity, osteoblasts and osteocytes before and after KT, verify an association between bone remodeling process (Turnover, Volume, and Mineralization-TMV classification), the osteocyte sclerostin expression to evaluate if there is a role of Wnt pathway, as well as the effect of ZA on these cells. METHODS:We studied 29 new living-donor KT patients. One group received ZA at the time of KT plus cholecalciferol for twelve months, and the other group received only cholecalciferol. Bone biopsies were performed at baseline and after 12 months of treatment. Histomorphometric evaluation was performed in bone and bone marrow adipocytes. Sclerostin (Scl) expression in osteocytes was evaluated by immunohistochemistry. RESULTS:Some bone marrow adiposity parameters were increased before KT. After KT, some of them remained increased and they worsened with the use of ZA. In the baseline, lower bone Volume and Turnover, were associated with increased bone marrow adiposity parameters (some of them). After KT, both groups showed the same associations. Osteocyte Scl expression after KT decreased with the use of ZA. We observed also an inverse association between bone adiposity parameters and lower osteocyte sclerostin expression 12 months after KT. CONCLUSION:In conclusion, the present study suggests that KT fails to normalize bone marrow adiposity, and it even gets worse with the use of ZA. Moreover, bone marrow adiposity is inversely associated with bone Volume and Turnover, which seems to be accentuated by the antiresorptive therapy.http://europepmc.org/articles/PMC5969759?pdf=render |
| spellingShingle | Mariel J Hernandez Luciene M Dos Reis Igor D Marques Maria J Araujo Cesar A M Truyts Ivone B Oliveira Fellype C Barreto Elias David-Neto Melani R Custodio Rosa M Moyses Ezequiel Bellorin-Font Vanda Jorgetti The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis. PLoS ONE |
| title | The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis. |
| title_full | The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis. |
| title_fullStr | The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis. |
| title_full_unstemmed | The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis. |
| title_short | The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis. |
| title_sort | effect of vitamin d and zoledronic acid in bone marrow adiposity in kidney transplant patients a post hoc analysis |
| url | http://europepmc.org/articles/PMC5969759?pdf=render |
| work_keys_str_mv | AT marieljhernandez theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT lucienemdosreis theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT igordmarques theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT mariajaraujo theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT cesaramtruyts theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT ivoneboliveira theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT fellypecbarreto theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT eliasdavidneto theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT melanircustodio theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT rosammoyses theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT ezequielbellorinfont theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT vandajorgetti theeffectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT marieljhernandez effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT lucienemdosreis effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT igordmarques effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT mariajaraujo effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT cesaramtruyts effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT ivoneboliveira effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT fellypecbarreto effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT eliasdavidneto effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT melanircustodio effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT rosammoyses effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT ezequielbellorinfont effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis AT vandajorgetti effectofvitamindandzoledronicacidinbonemarrowadiposityinkidneytransplantpatientsaposthocanalysis |